Edition:
United States

Apricus Biosciences Inc (APRI.OQ)

APRI.OQ on NASDAQ Stock Exchange Capital Market

2.25USD
24 Mar 2017
Change (% chg)

$-0.04 (-1.75%)
Prev Close
$2.29
Open
$2.40
Day's High
$2.40
Day's Low
$2.25
Volume
18,693
Avg. Vol
139,211
52-wk High
$15.30
52-wk Low
$1.10

Latest Key Developments (Source: Significant Developments)

Apricus Biosciences Q4 loss per share $0.04
Monday, 13 Mar 2017 04:13pm EDT 

Apricus Biosciences Inc : Apricus biosciences provides corporate update, fourth quarter and full year 2016 financial results . Q4 loss per share $0.04 . Apricus biosciences inc says vitaros u.s. Nda re-submission on track for q3 2017 .Q4 revenue $400,000.  Full Article

Apricus Biosciences announces sale of ex-U.S. Vitaros assets, rights to Ferring Pharmaceuticals
Wednesday, 8 Mar 2017 04:01pm EST 

Apricus Biosciences Inc : Apricus biosciences announces sale of ex-u.s. Vitaros assets and rights to ferring pharmaceuticals . Apricus biosciences inc - apricus will retain its vitaros rights in u.s. . Apricus biosciences inc - remains on track to re-submit vitaros nda to fda in q3 of 2017 . Says ferring has agreed to pay apricus an upfront payment of $11.5 million .Says ferring has aso agreed to pay apricus up to an additional $700,000 with respect to certain product inventory.  Full Article

Apricus Biosciences and certain investors mutually agreed to terminate certain securities purchase agreement
Wednesday, 28 Sep 2016 08:37am EDT 

Apricus Biosciences Inc : On Sept 27, co and certain investors mutually agreed to terminate certain securities purchase agreement, dated Sept 22 . Entered into a new securities purchase agreement for sale by co of 13.1 million shares of co's common stock, par value $0.001per share .Net proceeds are expected to be approximately $4.2 million and will be used for general corporate and working capital purposes.  Full Article

Apricus Biosciences to issue about 13.1 mln shares at $0.35 per share
Friday, 23 Sep 2016 08:00am EDT 

Apricus Biosciences Inc [APRI.O] : Apricus Biosciences announces $4.6 million registered direct offering .In connection with offering, will issue about 13.1 million registered shares of common stock at a purchase price of $0.35 per share.  Full Article

Apricus Biosciences says gets $4.5 mln in upfront payments from Ferring
Monday, 15 Aug 2016 07:00am EDT 

Apricus Biosciences Inc : Company's partner in United Kingdom, has received United Kingdom marketing authorization for Vitaros .Under terms of agreement, Apricus has received a total of $4.5 million in upfront payments from Ferring.  Full Article

Apricus Biosciences announces completion of transfer of Vitaros German marketing authorization to Ferring Pharmaceuticals
Wednesday, 10 Aug 2016 07:00am EDT 

Apricus Biosciences Inc :Ferring Pharmaceuticals, company's new partner in Germany, has received German marketing authorization for Vitaros.  Full Article

Apricus Biosciences Q2 shr loss $0.05
Thursday, 4 Aug 2016 04:01pm EDT 

Apricus Biosciences Inc : Q2 loss per share $0.05 . Q2 earnings per share view $-0.08 -- Thomson Reuters I/B/E/S .Apricus biosciences provides corporate update and second quarter financial results.  Full Article

Apricus Biosciences enters into common stock purchase agreement with Aspire Capital
Wednesday, 6 Jul 2016 08:00am EDT 

Apricus Biosciences Inc : Apricus Biosciences enters into common stock purchase agreement with Aspire Capital . Aspire Capital will complete an initial purchase of 2.5 million shares of common stock for proceeds of $1.0 million .Aspire Capital to purchase up to $6 million in additional shares of common stock over next 24 months.  Full Article

Apricus Biosciences reports Q1 loss per share of $0.05
Monday, 9 May 2016 07:12am EDT 

Apricus Biosciences Inc : To continue to reduce operating expenses with goal of achieving reductions of about 30% in 2016, 60% in 2017 compared to 2015 . Apricus biosciences provides corporate update and first quarter financial results . Q1 loss per share $0.05 . Q1 revenue $600,000 versus $500,000 . Q1 revenue view $922,000 -- Thomson Reuters I/B/E/S .Q1 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S.  Full Article

Apricus Biosciences Inc announces $10 mln registered direct offering
Wednesday, 13 Jan 2016 07:00am EST 

Apricus Biosciences Inc:Announces $10 million registered direct offering.Agreements with certain institutional investors for 11.4 million shares of common stock and warrants to buy up to 5.7 million shares.  Full Article

More From Around the Web

BRIEF-Apricus Biosciences announces sale of ex-U.S. Vitaros assets, rights to Ferring Pharmaceuticals

* Apricus biosciences announces sale of ex-u.s. Vitaros assets and rights to ferring pharmaceuticals